Analysis of the European Bipolar-disorder Therapeutics Market

Improving New Drug Formulations and Strong Product Pipelines Expected to Restore Growth beyond 2013

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service provides an assessment of the European bipolar-disorder therapeutics market, maps the key trends and dynamics shaping the industry, provides valuable insights on pipeline analysis and competitive landscape and offers strategic recommendations for the success of the market participants. This study provides an in-depth analysis of the market in terms of the three major classes of drugs used for treatment—atypical antipsychotics, mood stabilisers and anti-depressants—with a specific focus on the key five countries in Europe: Germany, France, the United Kingdom, Italy and Spain.

Table of Contents

Analysis of the European Bipolar-disorder Therapeutics Market, Executive SummarySummary of the European Bipolar-disorder Therapeutics MarketExecutive SummaryAnalysis of the European Bipolar-disorder Therapeutics Market, IntroductionIntroduction to the European Bipolar-disorder Therapeutics MarketResearch Scope and ObjectivesBipolar-disorder Disease SegmentationGeographic ScopeAnalysis of the European Bipolar-disorder Therapeutics Market, Market OverviewOverview of the European Bipolar-disorder Therapeutics MarketMarket OverviewAnalysis of the European Bipolar-disorder Therapeutics Market, Introduction to Bipolar DisorderIntroduction to Bipolar-disorder Disease Bipolar Disorder- DefinitionSigns and SymptomsDiagnosisDiagnostic Scales for Bipolar-disorderRisk FactorsAnalysis of the European Bipolar-disorder Therapeutics Market, Management of Bipolar DisorderManagement of Bipolar Disorder - Drugs Used and Treatment RegimenClassification of DrugsTreatment of Acute ManiaTreatment of DepressionTreatment of Mixed Episodes and Maintenance PhasePsychological InterventionAnalysis of the European Bipolar-disorder Therapeutics Market, EpidemiologyEpidemiology of Bipolar Disorder in EuropeDemographics by CountryPrevalence of Mood Disorders in EuropePrevalence and Mortality Rates of Bipolar Disorder by Age and GenderLifetime Prevalence of Co-morbidities with Bipolar DisorderBipolar-disorder Treatment Statistics in EuropeAnalysis of the European Bipolar-disorder Therapeutics Market, External Challenges: Market Drivers and Restraints for the Total MarketIndustry Challenges, Market Drives and Restraints of the European Bipolar-disorder Therapeutics MarketIndustry Challenges- Impact and DurationMarket Drivers and RestraintsImpact Mapping of Drivers and RestraintsAnalysis of the European Bipolar-disorder Therapeutics Market, Market Trends and Revenue Forecasts for the Total MarketMarket Engineering Measurements and Revenue ForecastsMarket Engineering MeasurementsForecast AssumptionsTotal Bipolar-disorder Therapeutics Market Revenue ForecastTotal Bipolar-disorder Therapeutics Market Revenue Forecast DiscussionBipolar-disorder Therapeutics Market Per Cent of Revenue by CountryAnalysis of the European Bipolar-disorder Therapeutics Market, Competitive Landscape AnalysisAnalysis of the Competitive Landscape of the European Bipolar-disorder Therapeutics MarketCompetitive StructureCompetitive Analysis: Profiling of Selected Key Market ParticipantsCompetitive Analysis: Promising Companies in the FutureBipolar-disorder Therapeutics Market Competitive LandscapeAnalysis of the Marketed Products for Bipolar DisorderMarketed Product Analysis — Bipolar-disorder MedicationMarketed Product Analysis — Key Patent ExpiriesAnalysis of the European Bipolar-disorder Therapeutics Market, Pipeline AnalysisAnalysis of Potential Bipolar Drug Candidates in PipelineLate-stage Product AnalysisPipeline AnalysisAnalysis of the European Bipolar-disorder Therapeutics Market, Cost AnalysisCost Analysis of the European Bipolar-disorder Therapeutics MarketEconomic Burden Due to Mood Disorders in EuropeCost Analysis of Mood DisordersCost Analysis of Bipolar DisordersAnalysis of the European Bipolar-disorder Therapeutics Market, Regulatory AnalysisRegulatory Analysis of the European Bipolar-disorder Therapeutics MarketThe EU Regulatory Framework for Bipolar DisordersEfficacy CriteriaStudy Population and DesignTherapeutic StudiesSafety AspectsAnalysis of the European Bipolar-disorder Therapeutics Market, Atypical Antipsychotic Drugs Segment BreakdownAnalysis of the Atypical Antipsychotic Drugs Segment for Bipolar DisorderMarket Engineering MeasurementsAtypical Antipsychotic Drugs Segment Revenue ForecastAtypical Antipsychotic Drugs Segment Revenue Forecast DiscussionAtypical Antipsychotic Drugs Segment End-user AnalysisAtypical Antipsychotic Drugs Segment - A Physician's PerceptionAtypical Antipsychotic Drugs Segment Competitive Analysis—Market ShareAtypical Antipsychotic Drugs Segment Market Share AnalysisAtypical Antipsychotic Drugs Segment - Key Marketed Product AnalysisAnalysis of the European Bipolar-disorder Therapeutics Market, Mood-stabilising DrugsAnalysis of the Mood-stabilising Drugs Segment for Bipolar DisorderMarket Engineering MeasurementsMood-stabilising Drugs Segment Revenue ForecastMood-stabilsing Drugs Segment Revenue Forecast DiscussionMood-stabilising Drugs Segment End-user AnalysisMood-stabilising Drugs Segment - A Physician's PerspectiveMood-stabilising Drugs Segment Competitive Analysis—Market ShareMood-stabilising Drugs Segment Market Share AnalysisMood-stabilising Drugs Segment - Key Marketed Products AnalysisAnalysis of the European Bipolar-disorder Therapeutics Market, Anti-depressant Drugs Segment BreakdownAnalysis of the Anti-depressant Drugs Segment for Bipolar DisorderMarket Engineering MeasurementsAnti-depressant Drugs Segment Revenue ForecastAnti-depressant Drugs Segment Revenue Forecast DiscussionAnti-depressanr Drugs Segment End-user AnalysisAnti-depressant Drugs Segment - A Physician's PerspectiveAnti-depressant Drugs Segment Competitive Analysis—Market ShareAnti-depressant Drugs Segment - Market Share AnalysisAnti-depressant Drugs Segment - Key Marketed Products AnalysisAnalysis of the European Bipolar-disorder Therapeutics Market, Germany BreakdownGermany Bipolar-disorder Therapeutics MarketGermany Market - Market Engineering MeasurementsGermeny Market Revenue ForecastAnalysis of the European Bipolar-disorder Therapeutics Market, France BreakdownFrance Bipolar-disorder Therapeutics MarketFrance Market - Market Engineering MeasurementsFrance Market Revenue ForecastAnalysis of the European Bipolar-disorder Therapeutics Market, The United Kingdom BreakdownThe United Kingdom Biolar-disorder Therapeutics MarketThe United Kingdom Market - Market Engineering MeasurenmentsThe United Kingdom Market Revenue ForecastAnalysis of the European Bipolar-disorder Therapeutics Market, Italy BreakdownItaly Bipolar-disorder Therapeutics MarketItaly Market - Market Engineering MeasurementsItaly Market Revenue ForecastAnalysis of the European Bipolar-disorder Therapeutics Market, Spain BreakdownSpain Bipolar-disorder Therapeutics MarketSpain Market - Market Engineering MeasurementsSpain Market Revenue ForecastAnalysis of the European Bipolar-disorder Therapeutics Market, The Last WordConclusions and ImplicationsThe Last Word—Three Big PredictionsAnalysis of the European Bipolar-disorder Therapeutics Market, Summary of Major FindingsSummary of Major Findings of the European Bipolar-disorder Therapeutics MarketSummary of Major FindingsAnalysis of the European Bipolar-disorder Therapeutics Market, AppendixSupport DatabasesMarket Engineering MethodologyDecision Support DatabasesList of AbbreviationsDatabase of Key Industry Participants




Keyword1

Keyword2

Keyword3

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.